Skip Nav Destination
Close Modal
Update search
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Journal
Article Type
Issue Section
Date
Availability
1-13 of 13
Keywords: Low-density lipoprotein
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Journal Articles
Subject Area:
Cardiovascular System
Lourdes Vicent, Albert Ariza-Solé, Pablo Díez-Villanueva, Oriol Alegre, Juan Sanchís, Ramón López-Palop, Francesc Formiga, Violeta González-Salvado, Héctor Bueno, Francisco Marín, Cinta Llibre, Isaac Llaó, María T. Vidán, Emad Abu-Assi, Jaime Aboal, Manuel Martínez-Sellés
Journal:
Cardiology
Cardiology (2019) 143 (1-2): 14–21.
Published Online: 07 August 2019
... elevation acute coronary syndrome Statins Low-density lipoprotein Mortality Octogenarians Frailty Visual Abstract Visual Abstract. © 2019 S. Karger AG, Basel 2019 Copyright / Drug Dosage / Disclaimer Copyright: All rights reserved. No part of this publication may be translated...
Journal Articles
Subject Area:
Cardiovascular System
Gideon Charach, Alexander Rabinovich, Argov Ori, Dov Weksler, David Sheps, Lior Charach, Moshe Weintraub, Jacob George
Journal:
Cardiology
Cardiology (2013) 127 (1): 45–50.
Published Online: 12 December 2013
... of low levels of low-density lipoprotein cholesterol (LDL-c) on cardiac mortality in a cohort of elderly patients with moderate and severe HF. Methods: Chronic HF patients from the HF Unit at the Tel-Aviv Medical Center (n = 212, 77% males) with an average NYHA classification of 2.8, a mean age of 76.9...
Journal Articles
Subject Area:
Cardiovascular System
Journal:
Cardiology
Cardiology (1989) 76 (Suppl. 1): 45–54.
Published Online: 12 November 2008
... total cholesterol, low-density lipoprotein (LDL) cholesterol, very-low-density lipoprotein (VLDL) cholesterol and triglyceride levels in patients with hyperlipoproteinemia or familial hypercholesterolemia. These lipoprotein changes have been associated with a regression of tendon xanthoma...
Journal Articles
Subject Area:
Cardiovascular System
Journal:
Cardiology
Cardiology (1989) 76 (Suppl. 1): 75–82.
Published Online: 12 November 2008
...David H. Blankenhorn 12 11 2008 Atherosclerosis, angiographic assessment Lipid-lowering therapy Coronary heart disease Plasma cholesterol levels, reduction Low-density lipoprotein 1989 Copyright / Drug Dosage / Disclaimer Copyright: All rights reserved. No part...
Journal Articles
Subject Area:
Cardiovascular System
Journal:
Cardiology
Cardiology (1989) 76 (Suppl. 1): 14–22.
Published Online: 12 November 2008
... decrease in very-low-density lipoprotein (VLDL) cholesterol levels (p < 0.01) and a rise in high-density lipoprotein (HDL) cholesterol levels (p < 0.01) in 227 subjects with both type IIa and IIb hyperlipidemias. Low-density lipoprotein (LDL) cholesterol levels also fell: 20.3% in type IIa and 6...
Journal Articles
Subject Area:
Cardiovascular System
Journal:
Cardiology
Cardiology (1989) 76 (Suppl. 1): 83–100.
Published Online: 12 November 2008
... the low-density-lipoprotein-lowering effect of probucol appears quite variable. The use of low doses of bile acid sequestrants (4–8 g/day of cholestyramine or 5–10 g/day of colestipol) in combination with lovastatin, simvastatin, or probucol provides a therapeutic regimen that is usually well tolerated...
Journal Articles
Subject Area:
Cardiovascular System
Journal:
Cardiology
Cardiology (1989) 76 (Suppl. 1): 23–32.
Published Online: 12 November 2008
... treatment also decreased very low-density lipoprotein (VLDL) TG, total cholesterol and VLDL cholesterol, and increased high-density lipoprotein levels. Adverse effects of fenofibrate were minimal compared with placebo and resolved when the drug was discontinued. Overall, fenofibrate was found...
Journal Articles
Subject Area:
Cardiovascular System
Journal:
Cardiology
Cardiology (1989) 76 (Suppl. 1): 1–13.
Published Online: 12 November 2008
..., reducing the total cholesterol level by 20–25% in type Ha patients and triglycerides by 40–60% in type lib and IV patients. High levels of low-density lipoprotein cholesterol are reduced and, where low at baseline, high-density lipoprotein levels are increased. An associated activity is a 10–28% reduction...
Journal Articles
Subject Area:
Cardiovascular System
Journal:
Cardiology
Cardiology (1989) 76 (Suppl. 1): 65–74.
Published Online: 12 November 2008
... phosphatase, cholesterol 7α-hydroxylase, and 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase. Activation of phosphatidic acid phosphatase promotes hepatic triglyceride (TG) synthesis, induces secretion of TG-rich, very low density lipoprotein particles, and consequently, increases plasma TG levels...
Journal Articles
Subject Area:
Cardiovascular System
Journal:
Cardiology
Cardiology (1989) 76 (Suppl. 1): 55–64.
Published Online: 12 November 2008
...John LaRosa Both alone and in combination with other lipid-lowering drugs, the bile acid sequestrants cholestyramine and colestipol, are excellent agents for lowering circulating low-density lipoprotein (LDL) cholesterol levels. They have been shown to lower the incidence of new coronary events...
Journal Articles
Subject Area:
Cardiovascular System
Journal:
Cardiology
Cardiology (1990) 77 (Suppl. 4): 39–49.
Published Online: 12 November 2008
... nightly (n=17) or gemfibrozil 600 mg twice daily (n=8), and in stratum 2 (cholesterol levels ≧ 7.8 mmol/l [≧ 302 mg/dl]), patients received either lovastatin 40 mg nightly (n=23) or gemfibrozil 600 mg b.i.d. (n=19) for 6 weeks. Low-density lipoprotein (LDL) cholesterol levels were reduced significantly...
Journal Articles
Subject Area:
Cardiovascular System
Journal:
Cardiology
Cardiology (1987) 74 (1): 2–21.
Published Online: 11 November 2008
...Conrad B. Blum; Robert I. Levy A large and convincing body of evidence links increased coronary risk with elevated plasma levels of low-density lipoprotein (LDL) cholesterol. Cholesterol in atherosclerotic lesions originates from that circulating in the blood bound to LDL. Even mild degrees...
Journal Articles
Subject Area:
Cardiovascular System
Journal:
Cardiology
Cardiology (2002) 97 (2): 59–66.
Published Online: 25 April 2002
... effective at lowering levels of low-density lipoprotein cholesterol (LDL-C). New formulations of drugs such as nicotinic acid can improve treatment regimens and reduce unpleasant side-effects, thereby improving patient compliance with this therapy. In terms of developing novel drugs, the introduction...